Cognios Capital’s Amgen AMGN Stock Holding History

Cognios Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-103	Closed	-$20K	–	19
2020 Q1	$20K	Buy	+103	New	+$22.5K	0.01%	215
2018 Q4	–	Sell	-5,768	Closed	-$1.2M	–	135
2018 Q3	$1.2M	Buy	+5,768	New	+$1.14M	0.49%	113

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cognios Capital's AMGN Position: Q2 2020 in Review

Cognios Capital sold out of Amgen (AMGN) in Q2 2020, closing a stake of 103 shares — an estimated $20K sold.

Cognios Capital first reported a position in AMGN in Q3 2018 and held it in 2 quarters. The position peaked at $1.2M in Q3 2018. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

Cognios Capital reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
Cognios Capital sold 103 Amgen shares in Q2 2020, an estimated $20K.
Cognios Capital first reported a position in Amgen in Q3 2018 and held it in 2 quarters.
Cognios Capital's Amgen position peaked at $1.2M in Q3 2018.
2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.